John Kastelein, professor of medicine, University of Amsterdam, presented data from a retrospective analysis that demonstrated a significant reduction in Major Adverse Cardiovascular Events (MACE) in patients with homozygous and heterozygous familial hypercholesterolemia (FH) treated with Kynamro (
heterozygous הגייה עם משמעויות, מילים נרדפות, הפכים, תרגומים, משפטים ועוד